MRNA vs NAUT · rev $145.0M vs $103.4M cap
Moderna Inc (MRNA) versus Nautilus Biotechnology Inc (NAUT) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Nautilus Biotechnology Inc (NAUT) is a biotechnology company listed on US.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
NAUT does not have a complete income-statement cache yet.
MRNA currently screens at market cap $24.52B. NAUT currently screens at market cap $103.4M.
Not investment advice. Open the MRNA and NAUT stock pages for the full models.
Not investment advice.